Lipid Controls
Echelon Biosciences Research Labs SHUTTLE PIP KIT PI(3 5)P2
Echelon Biosciences - Shuttle PIP Kit - P-9035 - PI(3,5)P2 This item is non returnable
Avanti Polar Lipids CARDIOLIPIN IN CHLOROFORM 2
Cardiolipin (Heart, Bovine-Disodium Salt). 383907-10-6
Avanti Polar Lipids 14:0 PC (DMPC) | 18194-24-6 | MFCD00036901 | 25mg
14:0 PC (DMPC) | Putity: >99% | MW: 677.95 | 18194-24-6 | MFCD00036901 | 25mg
Echelon Biosciences Research Labs SHUTTLE PIP KIT PI(3)P
Echelon Biosciences - Shuttle PIP Kit - P-9003 - PI(3)P This item is non returnable
eMolecules 104162-47-2 | Medchem Express | DODMA | 50mg | 719835653 | HY-112755 | MFCD22200991 | 620.104 | C41H81NO2
Ambeed | Methyl 2-hydroxy-4-(4455-tetramethyl-132-dioxaborolan-2-yl)benzoate | 100mg | 588343181 | A722212 | 1073371-99-9 | MFCD08458200 | 278.110 | C14H19BO5
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Cayman Chemical 1 3DIoloyl2ElaIdoyl Glyce 25mg
A triacylglycerol; has been used to study the effects of unsaturation and sn-2 substitution on the polymorphic behavior of triacylglycerols
Medchemexpress LLC DLin-K-C3-DMA | 1217306-46-1 | 98.59% | 656.12 | 5 MG
DLin-K-C3-DMA is a cationic lipid utilized in the synthesis of nucleic acid-lipid particles for the delivery of nucleic acids.
- Utilized in the synthesis of nucleic acid-lipid particles
- For delivery of nucleic acids
- Intended for research use only
Cayman Chemical DLIn-MC4-DMA 50mg
An ionizable cationic lipid (pKa = 6.93); LNPs containing DLin-MC4-DMA and encapsulating siRNA for F7 reduce its gene expression levels in mice
Cayman Chemical DLIn-KC2-DMA 1mg
An ionizable cationic lipid (pKa = 6.7); has been used in the formation of LNPs encapsulating siRNA or plasmid DNA for use in vitro and in vivo; LNPs containing DLin-KC2-DMA selectively accumulate in the liver after i.v. or i.m. administration in mice or localize to the retinal pigment epithelium and Müller glia after subretinal administration; DLin-KC2-DMA-containing LNPs encapsulating F7-targeted siRNA reduce serum Factor VII levels in mice; DLin-KC2-DMA-containing LNPs encapsulating AR-targeted siRNA decrease serum PSA and tumor androgen receptor levels in an LNCaP prostate cancer mouse xenograft model